Castle Biosciences Inc. (CSTL) Reports Q4 EPS of $0.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to Castle Biosciences Inc. (CSTL) Reports Q4 EPS of $0.11

Castle Biosciences Announces Fourth Quarter and Full-Year 2019 Results

March 10, 2020 4:05 PM EDT

Q4 2019 recognized revenues of $17.6 million, compared to $11.4 million in Q4 2018
Q4 2019 adjusted revenues of $17.6 million, compared to $6.2 million in Q4 2018
Full-year 2019 revenues of $51.9 million, compared to $22.8 million in 2018
Full-year 2019 gross margin was 86%
2020 revenue guidance of $61-64 million
Conference call and webcast today at 4:30 p.m. ET

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its financial results for the fourth quarter and twelve months ended December 31,... More